Cargando…

Correction to: Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19

Detalles Bibliográficos
Autores principales:	Kistner, Anna, Tamm, Chen, Svensson, Ann Mari, Beckman, Mats O., Strand, Fredrik, Sköld, Magnus, Nyrén, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482954/ https://www.ncbi.nlm.nih.gov/pubmed/34592952 http://dx.doi.org/10.1186/s12882-021-02536-2

Ejemplares similares

Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19
por: Kistner, Anna, et al.
Publicado: (2021)

Widespread Parenchymal Abnormalities and Pulmonary Embolism on Contrast-Enhanced CT Predict Disease Severity and Mortality in Hospitalized COVID-19 Patients
por: Jalde, Francesca Campoccia, et al.
Publicado: (2021)

A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infection
por: Beckman, Mats, et al.
Publicado: (2020)

Development of liposomal contrast agent with high iodine concentration and minimal effect on renal function
por: Ochi, Tomoko, et al.
Publicado: (2023)

Impact of Iodinated Contrast on Renal Function and Hemodynamics in Rats with Chronic Hyperglycemia and Chronic Kidney Disease
por: Fernandes, Sheila Marques, et al.
Publicado: (2016)

Iodine Nutrition and Iodine Supplement Initiation in Association with Thyroid Function in Mildly-to-Moderately Iodine-Deficient Pregnant and Postpartum Women
por: Næss, Synnøve, et al.
Publicado: (2021)

Changes in Renal Function in Elderly Patients Following Intravenous Iodinated Contrast Administration: A Retrospective Study
por: Alsafi, Ali, et al.
Publicado: (2014)

Renal Safety of Iodinated Contrast Media Depending on Their Osmolarity – Current Outlooks
por: Mruk, Bartosz
Publicado: (2016)

Update on the renal toxicity of iodinated contrast drugs used in clinical medicine
por: Andreucci, Michele, et al.
Publicado: (2017)

Key Considerations regarding the Renal Risks of Iodinated Contrast Media: The Nephrologist’s Role
por: Mehta, Ravindra, et al.
Publicado: (2023)

Harmful effect of repetitive intravenous iodinated contrast media administration on the long-term renal function of patients with early gastric cancer
por: Koo, Ja Ho, et al.
Publicado: (2023)

Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro
por: Dallaudiere, B., et al.
Publicado: (2018)

Lung perfusion disturbances in nonhospitalized post‐COVID with dyspnea—A magnetic resonance imaging feasibility study
por: Yu, Jimmy Z., et al.
Publicado: (2022)

Contrast nephropathy in patients with well-preserved renal function
por: Tekin, Göknur, et al.
Publicado: (2015)

Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose
por: Rutten, Annemarieke, et al.
Publicado: (2010)

Gadolinium based contrast agents in current practice: Risks of accumulation and toxicity in patients with normal renal function
por: Ranga, Anju, et al.
Publicado: (2017)

Iodine Intake is Associated with Thyroid Function in Mild to Moderately Iodine Deficient Pregnant Women
por: Abel, Marianne Hope, et al.
Publicado: (2018)

Comparison of Renal Damage by Iodinated Contrast or Gadolinium in an Acute Renal Failure Rat Model Based on Serum Creatinine Levels and Apoptosis Degree
por: Kwak, Hyo-Sung, et al.
Publicado: (2005)

Preclinical Studies of a Kidney Safe Iodinated Contrast Agent
por: Rowe, Elizabeth S., et al.
Publicado: (2016)

Comparison of Rhenium and Iodine as Contrast Agents in X-Ray Imaging
por: De La Vega, José Carlos, et al.
Publicado: (2021)

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD
por: Mavrakanas, Thomas A., et al.
Publicado: (2018)

Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast
por: van Welie, N, et al.
Publicado: (2020)

Impact of contrast-enhanced ultrasound in patients with renal function impairment
por: Girometti, Rossano, et al.
Publicado: (2017)

The moderate‐intensity continuous exercise maintains renal blood flow and does not impair the renal function
por: Kawakami, Shotaro, et al.
Publicado: (2022)

Effect of iodinated contrast media on renal perfusion: A randomized comparison study in pigs using quantitative contrast-enhanced ultrasound (CEUS)
por: Lamby, Philipp, et al.
Publicado: (2017)

Gadolinium as a contrast agent for infusion sialograms in patients with iodine allergy
por: Sabotin, Ryan P., et al.
Publicado: (2023)

Evaluation of renal function in rats with moderate and mild brain trauma
por: Tekin Neijmann, Şebnem, et al.
Publicado: (2022)

Mild to Moderate Iodine Deficiency and Inadequate Iodine Intake in Lactating Women in the Inland Area of Norway
por: Groufh-Jacobsen, Synne, et al.
Publicado: (2020)

General Anesthetic Agents and Renal Function after Nephrectomy
por: Lee, Ho-Jin, et al.
Publicado: (2019)

Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers
por: Karimi, Reza, et al.
Publicado: (2014)

Prophylactic Intravenous Hydration to Protect Renal Function From Intravascular Iodinated Contrast Material (AMACING): Long-term Results of a Prospective, Randomised, Controlled Trial
por: Nijssen, Estelle C., et al.
Publicado: (2018)

Renal Safety of Repeated Intravascular Administrations of Iodinated or Gadolinium-Based Contrast Media within a Short Interval
por: Kwon, Chiheon, et al.
Publicado: (2021)

Differential renal proteomics analysis in a novel rat model of iodinated contrast-induced acute kidney injury
por: Deng, Ying-Hao, et al.
Publicado: (2023)

Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
por: Joo, Dong Jin, et al.
Publicado: (2014)

Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment
por: Perera, Vidya, et al.
Publicado: (2022)

Moderate to severe renal impairment cannot be reliably detected from medical history alone: Implications for the use of Gadolinium-based contrast agents
por: Carpenter, John-Paul, et al.
Publicado: (2009)

Contrast-Induced Nephropathy and Oxygen Pretreatment in Patients With Impaired Renal Function
por: Sekiguchi, Haruki, et al.
Publicado: (2017)

Effects of adding local anesthetic and iodinated contrast agents to the paramagnetic contrast solution in direct MR arthrography
por: Nogueira-Barbosa, Marcello Henrique
Publicado: (2015)

Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study
por: Rath, Jakob, et al.
Publicado: (2017)

Proteomic Analysis of Iodinated Contrast Agent-Induced Perturbation of Thyroid Iodide Uptake
por: Hichri, Maha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5jgq6tesbkqbpm4i40ogrtfs8q